Search

Your search keyword '"Ueda Ryuzo"' showing total 1,865 results

Search Constraints

Start Over You searched for: Author "Ueda Ryuzo" Remove constraint Author: "Ueda Ryuzo"
1,865 results on '"Ueda Ryuzo"'

Search Results

2. Clinical landscape of TP73 structural variants in ATL patients

7. Regulatory T‐cells activated in metastatic draining lymph nodes possibly suppress cancer immunity in cancer tissues of head and neck squamous cell cancer

8. Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study

10. CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia

11. Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors

13. Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma

17. Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels

25. Data from Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma

26. Supplementary Fig. from Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines

27. Supplementary Figure 1, Tables S1-6 from Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma

28. Supplementary Figure 3 from Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients

29. Clinical landscape of TP73structural variants in ATL patients

30. Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens

31. Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease

32. Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study

33. Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumors

34. Landscape of immunoglobulin heavy chain gamma gene class switch recombination in patients with adult T-cell leukemia–lymphoma

36. CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment

38. Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma

39. Immune Status of Cervical Lymph Nodes in Head and Neck Cancer—A Surgical Oncology Perspective.

40. Global real-time quantitative reverse transcription-polymerase chain reaction detecting proto-oncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myeloma

42. Angioimmunoblastic T-cell lymphoma mice model

46. Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma

47. In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among Patients

48. Identification of cisplatin-resistant factor by integration of transcriptomic and proteomic data using head and neck carcinoma cell lines

Catalog

Books, media, physical & digital resources